Interferon gamma in cancer immunotherapy

Cancer Med. 2018 Sep;7(9):4509-4516. doi: 10.1002/cam4.1700. Epub 2018 Jul 23.

Abstract

Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, we conducted an extensive literature search of recent 5-year studies about the roles of IFNγ signaling in both tumor immune surveillance and immune evasion. In addition to well-known functions, IFNγ signaling also induces tumor ischemia and homeostasis program, resulting in tumor clearance and tumor escape, respectively. The yin and the yang of IFNγ signaling are summarized. Thus, this review helps us to comprehensively understand the roles of IFNγ in tumor immunity, which contributes to better design and management of clinical immunotherapy approaches.

Keywords: IFNγ signaling; cancer immunotherapy; immune evasion; immune surveillance; transformed self.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunologic Factors / genetics
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Immunomodulation / drug effects*
  • Immunotherapy*
  • Interferon-gamma / genetics
  • Interferon-gamma / pharmacology
  • Interferon-gamma / therapeutic use*
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / immunology*
  • Signal Transduction
  • Tumor Escape / genetics
  • Tumor Escape / immunology
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology

Substances

  • Biomarkers
  • Immunologic Factors
  • Interferon-gamma